Discover Opportunities months before the RFP drops
Learn more →Retrieving contract details... Hang tight!
See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
Verified decision-maker contacts
Winning vendor information
Budget & renewal data
Clean & enrich your CRM automatically
Track contract spending & renewal dates
Analyze historical pricing trends
Identify upcoming opportunities
Get complete source documentation & analysis
FDA Office of Acquisition Grant Services
This contract includes 1 purchase order from Aug 27, 2025 to Aug 27, 2025
| Buyer | Vendor | Issued Date | Quantity |
|---|---|---|---|
| FDA Office of Acquisition Grant Services | University of Maryland, Baltimore | Aug 27, 2025 | 1 |
Full Purchase Intelligence Available
Get complete pricing, descriptions, and financial details for all 1 purchase orders
Unlock Full Details →See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
No public files available for this contract.
Contract documentation may be available through official government sources or agency portals. Starbridge can help you track down and retrieve these files.
FDA Office of Acquisition Grant Services
RESEARCH STUDY "INVESTIGATING THE IMPACT OF API PURITY, EXCIPIENT SOURCE AND MANUFACTURING PROCESS ON PERFORMANCE AND QUALITY OF COMPLEX SIRNA LIPID NANOPARTICLES".
Effective Date
Sep 21, 2023
Expires
Effective: Sep 21, 2023
FDA Office of Acquisition Grant Services
Expires:
RESEARCH STUDY "INVESTIGATING THE IMPACT OF API PURITY, EXCIPIENT SOURCE AND MANUFACTURING PROCESS ON PERFORMANCE AND QUALITY OF COMPLEX SIRNA LIPID NANOPARTICLES".
ActiveFDA Office of Acquisition Grant Services
THE U.S. FOOD AND DRUG ADMINISTRATION HEREBY ISSUES A FIRM-FIXED PRICE CONTRACT TO PROCURE SERVICES TO SUPPORT THE STUDY TITLED, INCORPORATING WOMEN'S EXPERIENCES AND PRIORITIZATION OF TREATMENT OUTCOMES INTO REGULATORY DECISION-MAKING FOR MEDIC
Effective Date
Sep 28, 2023
Expires
Effective: Sep 28, 2023
FDA Office of Acquisition Grant Services
Expires:
THE U.S. FOOD AND DRUG ADMINISTRATION HEREBY ISSUES A FIRM-FIXED PRICE CONTRACT TO PROCURE SERVICES TO SUPPORT THE STUDY TITLED, INCORPORATING WOMEN'S EXPERIENCES AND PRIORITIZATION OF TREATMENT OUTCOMES INTO REGULATORY DECISION-MAKING FOR MEDIC
ActiveFDA Office of Acquisition Grant Services
LEVERAGING REAL-WORLD DATA (RWD) TO INVESTIGATE THE NATURAL HISTORY OF RARE CANCERS TREATED IN THE US COMMUNITY ONCOLOGY SETTING TO PROVIDE CLINICAL CONTEXT TO INFORM FUTURE RESEARCH
Effective Date
Sep 20, 2023
Expires
Effective: Sep 20, 2023
FDA Office of Acquisition Grant Services
Expires:
LEVERAGING REAL-WORLD DATA (RWD) TO INVESTIGATE THE NATURAL HISTORY OF RARE CANCERS TREATED IN THE US COMMUNITY ONCOLOGY SETTING TO PROVIDE CLINICAL CONTEXT TO INFORM FUTURE RESEARCH
ActiveFDA Office of Acquisition Grant Services
BAA-FY24C3CP5-UNDERSTANDING HETEROGENEITY IN PREFERENCES FOR CLINICAL TRIAL PARTICIPATION IN DIVERSE PATIENT POPULATIONS.
Effective Date
Sep 24, 2024
Expires
Effective: Sep 24, 2024
FDA Office of Acquisition Grant Services
Expires:
BAA-FY24C3CP5-UNDERSTANDING HETEROGENEITY IN PREFERENCES FOR CLINICAL TRIAL PARTICIPATION IN DIVERSE PATIENT POPULATIONS.
ActiveSee who's winning contracts, track spending trends, and identify your best opportunities before your competition.
Schedule Your Demo →Verified decision-maker contacts
Winning vendor information
Budget & renewal data
Clean & enrich your CRM automatically
Track contract spending & renewal dates
Analyze historical pricing trends
Identify upcoming opportunities
Get complete source documentation & analysis